As part of their collaboration, the companies hope to integrate connectivity into drug-delivery devices in an effort to boost user experience and improve adherence.
“SHL has pushed to stay at the leading edge of advanced drug delivery for more than 20 years. As the healthcare industry embraces digital and people increasingly take their treatment into their own hands, our natural next step is connectivity that seamlessly captures high-quality data to form a detailed picture of the patient to improve clinical decision-making,” SHL Group founder and CEO Roger Samuelsson said in prepared remarks.
“QuiO is excited to contribute hardware technology and provide the full software-stack for SHL’s connected devices,” QuiO CEO Alexander Dahmani added. “Our ConnectedRx solution captures data directly from medical devices, structures and stores it in a secure cloud environment, and serves it to a suite of powerful applications that enable patients, clinicians, and customers to benefit from the data.”